Buy Prolixin Online

(Fluphenazine Hydrochloride)

The active ingredient in Permitil is fluphenazine hydrochloride.

Fluphenazine works by blocking dopamine receptors in the brain. Dopamine is a neurotransmitter involved in mood, behaviour, and perception. By reducing dopamine activity, this medication helps control symptoms of schizophrenia and other psychotic disorders. This mechanism of action helps improve thinking, mood stability, and behavior over time.

Follow all directions given to you by your doctor and read all documents provided, including the full Prescribing Information, FDA-Approved Product Labeling, Instructions for Use, and Medication Guide before using Permitil. However, the following is a synopsis of the general guidelines for the use of Permitil:

• Take Permitil exactly as prescribed by your healthcare provider.
• It may be taken as an oral tablet, solution, or elixir.
• Measure liquid doses carefully using a proper measuring device.
• It may be taken with or without food as directed.
• Take the medication at the same time each day.
• Do not stop taking the medication suddenly without medical advice.
• Avoid alcohol consumption, as it may increase drowsiness and side effects.
• If you miss a dose, take it as soon as you remember unless it is close to your next dose. Do not take two doses at once.

Some mild or common side effects of Permitil include:

• Dystonia (uncontrollable muscle contractions).
• Drowsiness.
• Dry mouth.
• Blurred vision.
• Loss of appetite.
• Fluid retention.
• Nausea.
• Constipation.
• Drooling.
• Headache.
• Lightheadedness.
• Blood pressure changes.

Some individuals may experience serious side effects while using Permitil. These side effects may require immediate medical attention. If you experience any of the following, contact your healthcare provider or seek emergency medical help:

• Neuroleptic malignant syndrome (NMS), with symptoms such as fever, muscle stiffness, and confusion.
• Tardive dyskinesia, which involves uncontrolled movements of the face or body.
• Severe allergic reactions with hives, swelling, or trouble breathing.
• Agranulocytosis, which may cause infections, fever, or sore throat.
• Severe hypotension or fainting.
• Signs of high prolactin levels (hyperprolactinemia), such as gynecomastia (enlarged breasts), sexual dysfunction, and absent or irregular menstrual periods.

These are not all of the possible side effects of Permitil. You should always seek medical advice from your healthcare provider for any questions or concerns about your medical condition or treatment. Read all patient information, medication guides, or drug information sheets that come with this medication. You can also report adverse effects to the Food and Drug Administration at www.fda.gov/medwatch or 1-800-FDA-1088.

Before starting Permitil, it is crucial to discuss any existing health conditions with your healthcare provider. You should be sure that your healthcare provider is aware of all your medical conditions, including if you have:

• Glaucoma.
• Heart conditions or blood pressure problems.
• Liver disease or blood disorders.
• A history of seizures.
• Dementia-related psychosis, especially in older adults.
• Additional precautions:
• Antipsychotic medications may increase the risk of serious side effects in elderly patients with dementia-related psychosis.
• Monitor for signs of movement disorders or abnormal muscle movements.
• Use caution when performing tasks that require alertness due to drowsiness.
• Regular follow-up with your healthcare provider is important.
• Do not use beverages containing caffeine (coffee, tea, and cola) or apple juice.

Boxed Warning

Increased risk of death in elderly patients with dementia-related psychosis.

Antipsychotic medications, including fluphenazine, are associated with a higher risk of death when used in this population.

Causes of death are often cardiovascular (such as heart failure or sudden death) or infectious (such as pneumonia).

Permitil is not approved for the treatment of dementia-related psychosis.

Permitil should not be used in the following situations:

• Known hypersensitivity to fluphenazine or other phenothiazines.
• Severe central nervous system depression.
• Bone marrow suppression or blood disorders.

Permitil may begin to improve symptoms within a few days, but full effects may take several weeks. Consistent use is important for managing symptoms of schizophrenia and other psychotic disorders.

When Permitil is taken with other prescription drugs, over-the-counter medications, vitamins, and supplements, it may change how they work or increase the frequency or severity of side effects. Make sure that you tell your healthcare professional about anything that you are taking to avoid any negative drug interactions, including:

• Other central nervous system depressants, which may increase drowsiness.
• Antihypertensive medications, which may increase the risk of low blood pressure.
• Anticholinergic drugs, which may increase side effects such as dry mouth and blurred vision.

Permitil is available in the following dosage forms:

• Oral tablets.
• Oral solution.
• Oral elixir.

The dose varies depending on the condition being treated and patient response. Your healthcare provider will determine the appropriate dose.

It should be stored at room temperature, away from the reach of children or pets.

Permitil (fluphenazine hydrochloride) was originally manufactured by Schering Corporation.

Yes, Permitil is available as a generic medication. The generic name is fluphenazine hydrochloride, or the brand name Prolixin.

Permitil should not be stopped suddenly without consulting your healthcare provider.

• Your healthcare provider may gradually reduce your dose.
• Stopping abruptly may worsen symptoms or cause withdrawal effects.
• Always follow medical advice when discontinuing treatment.

Permitil (fluphenazine) should generally be avoided during pregnancy unless the potential benefits to the mother outweigh the risks to the fetus.

Use of Permitil (fluphenazine) while breastfeeding is generally not recommended because there is no published experience or safety data on its use during lactation.